QCIG
IBB icon

Quad-Cities Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Quad-Cities Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-83
Closed -$8K – 853
2018
Q4 		$8K Sell
83
-30
-27% -$3.18K 0.01% 613
2018
Q3 		$14K Hold
113
– – 0.01% 573
2018
Q2 		$12K Buy
+113
New +$12.1K 0.01% 604

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Quad-Cities Investment Group's IBB Position: Q1 2019 in Review

Quad-Cities Investment Group sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 83 shares — an estimated $8K sold.

Quad-Cities Investment Group first reported a position in IBB in Q2 2018 and held it in 3 quarters. The position peaked at $14K in Q3 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

  • Quad-Cities Investment Group reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 83 iShares Biotechnology ETF shares in Q1 2019, an estimated $8K.
  • Quad-Cities Investment Group first reported a position in iShares Biotechnology ETF in Q2 2018 and held it in 3 quarters.
  • Quad-Cities Investment Group's iShares Biotechnology ETF position peaked at $14K in Q3 2018.
  • 670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Quad-Cities Investment Group's 13F filing for Q1 2019, filed 9 Apr 2019.